Parkinson DiseaseKT-DPNCT04326647
Short-term Effects Kinesiotaping (KT) on Balance and Gait in Parkinson's Disease (DP)
A study testing Kinesiotaping and Exercise in people with Parkinson Disease and Kinesiotaping, run by University of Castilla-La Mancha at 1 site in Spain.
Trial summary
To analyze the short-term effect of kinesiotaping in balance and gait on Parkinson's disease Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Parkinson Disease, Kinesiotaping
- What is being tested?
- Kinesiotaping and Exercise
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 10 participants
- Where
- 1 siteSpain
- Study dates
- 1 Jul 2020to 1 Aug 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Diagnosis of stage III PD, according to the Hoehn and Yahr scale.
- Subjects who are in the age range of 50 to 80 years.
- Acceptance of informed consent.
- Not present a musculoskeletal disorder or other neurological disease that interferes with balance and / or walking.
- Not having a diagnosed vestibular disorder.
Who cannot join
- Diagnosis of parkinsonism o Parkison-Like.
- Taking medications that may interfere with the different variables evaluated.
- Allergy to any component of the bandage.
- Being a pacemaker.
Trial locations and contacts
1 site in 1 country.
About this study
To analyze the short-term effect of kinesiotaping in balance and gait on Parkinson's disease
- Conditions
- Parkinson Disease, Kinesiotaping
- Being tested
- Kinesiotaping, Exercise
- Medical subject headings
- Parkinson Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
KinesiotapingOther
We used kinesiotaping in gastrocnemius and lumbar back
ExerciseOther
Exercises about balance and gait
| Study group | Role | What they receive |
|---|---|---|
| Kinesiotaping Group | Experimental | We used kinesiotaping (gastrocnemius and lumbar back) plus exercise Receives: Other: Kinesiotaping |
| Exercise Group | Active comparator | We used only exercise Receives: Other: Exercise |
What is being measured
The primary outcome is the main question the study is designed to answer.
Berg Test - T0
Berg Test pre-intervention
Measured: up to week
Berg Test - T1
Berg Test post-intervention two days
Measured: up to week
Berg Test - T2
Berg Test post-intervention seven days
Measured: up to week
Tinetti Gait Test - T0
Tinetti Gait Test pre-intervention
Measured: up to week
Tinetti Gait Test - T1
Tinetti Gait Test post-intervention two days
Measured: up to week
Tinetti Gait Test - T2
Tinetti Gait Test post-intervention seven days
Measured: up to week
Up & Go Test - T0
Up \& Go Test pre-intervention
Measured: up to week
Up & Go Test - T1
Up \& Go Test post-intervention two days
Measured: up to week
Up & Go Test - T2
Up \& Go Test post-intervention seven days
Measured: up to week
Parkinson's Disease Questionnaire - T0
Parkinson's Disease Questionnaire pre-intervention
Measured: up to month
Parkinson's Disease Questionnaire - T1
Parkinson's Disease Questionnaire post-intervention
Measured: up to month
surface electromyography -T0
surface electromyography pre-intervention
Measured: up to week
surface electromyography -T1
surface electromyography post-intervention two days
Measured: up to week
surface electromyography -T2
surface electromyography post-intervention seven days
Measured: up to week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Mar 2020
- Study start1 Jul 2020 (estimated)
- Primary completion1 Aug 2020 (estimated)
- Study completion1 Aug 2020 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Parkinson DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Care provider, Outcomes assessor
- Enrolment
- 10 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Castilla-La Mancha
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04326647
- Sponsor's protocol ID
- jma002
- Acronym
- KT-DP
- Status last verified
- Mar 2020
- First submitted
- 24 Mar 2020
- Last updated
- 30 Mar 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Mar 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Short-term Effects Kinesiotaping (KT) on Balance and Gait in Parkinson's Disease (DP)
- ClinicalTrials.gov ID
- NCT04326647
- Acronym / sponsor ID
- KT-DP / jma002
- Conditions
- Parkinson Disease, Kinesiotaping
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 10 participants (estimated)
- Lead sponsor
- University of Castilla-La ManchaUniversity, hospital or other
- Study start
- 1 Jul 2020 (estimated)
- Primary completion
- 1 Aug 2020 (estimated)
- Study completion
- 1 Aug 2020 (estimated)
- First posted
- 30 Mar 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To analyze the short-term effect of kinesiotaping in balance and gait on Parkinson's disease
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (care provider, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Kinesiotaping Group | Experimental | Other: KinesiotapingWe used kinesiotaping (gastrocnemius and lumbar back) plus exercise |
| Exercise Group | Active comparator | Other: ExerciseWe used only exercise |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (5 listed)
- Diagnosis of stage III PD, according to the Hoehn and Yahr scale.
- Subjects who are in the age range of 50 to 80 years.
- Acceptance of informed consent.
- Not present a musculoskeletal disorder or other neurological disease that interferes with balance and / or walking.
- Not having a diagnosed vestibular disorder.
Key exclusion criteria (4 listed)
- Diagnosis of parkinsonism o Parkison-Like.
- Taking medications that may interfere with the different variables evaluated.
- Allergy to any component of the bandage.
- Being a pacemaker.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| KinesiotapingWe used kinesiotaping in gastrocnemius and lumbar back | Other | Kinesiotaping Group |
| ExerciseExercises about balance and gait | Other | Exercise Group |
Primary outcome
Berg Test - T0
Time frame: up to week
Berg Test pre-intervention
Berg Test - T1
Time frame: up to week
Berg Test post-intervention two days
Berg Test - T2
Time frame: up to week
Berg Test post-intervention seven days
Tinetti Gait Test - T0
Time frame: up to week
Tinetti Gait Test pre-intervention
Tinetti Gait Test - T1
Time frame: up to week
Tinetti Gait Test post-intervention two days
Tinetti Gait Test - T2
Time frame: up to week
Tinetti Gait Test post-intervention seven days
Up & Go Test - T0
Time frame: up to week
Up \& Go Test pre-intervention
Up & Go Test - T1
Time frame: up to week
Up \& Go Test post-intervention two days
Up & Go Test - T2
Time frame: up to week
Up \& Go Test post-intervention seven days
Parkinson's Disease Questionnaire - T0
Time frame: up to month
Parkinson's Disease Questionnaire pre-intervention
Parkinson's Disease Questionnaire - T1
Time frame: up to month
Parkinson's Disease Questionnaire post-intervention
surface electromyography -T0
Time frame: up to week
surface electromyography pre-intervention
surface electromyography -T1
Time frame: up to week
surface electromyography post-intervention two days
surface electromyography -T2
Time frame: up to week
surface electromyography post-intervention seven days
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Mar 2020.
- Individual participant dataSharing planned: No
Related trials for Parkinson Disease
Enrolling by invitationObservational study
Genetic Studies of Lysosomal Storage Disorders
Lysosomal Storage Disorders, Gaucher Disease
Recruiting
Deep Brain Stimulation Surgery for Movement Disorders
Parkinson's Disease, Essential Tremor
Active, not recruitingPhase 2
A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy
Thymoma, Thymic Carcinoma
Active, not recruitingPhase 1/2
Repurposing Lithium for Parkinson's Disease: a RCT
Parkinson Disease
RecruitingPhase 3
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Non-small Cell Lung Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Kinesiotaping and Exercise in people with Parkinson Disease and Kinesiotaping, run by University of Castilla-La Mancha at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 30 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Javier Merino Andrés, MsC (925268800 ext. 5822, Javier.Merino@uclm.es), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Berg Test - T0 (time frame: up to week). The study lists 14 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2020; AzTrials last refreshed its copy on 26 Oct 2026.